Transforming Healthcare with Evidence

hayesinfo@hayesinc.com | 215-855-0615

We rely on Hayes to provide unbiased, evidence-based resources as an integral part of our technology assessment process.

Dr. Tony Melaragno
Chief Administrative Officer and Clinical VP of Research, Legacy Good Samaritan Hospital

GTE Topics for Pharmacogenetic

Topic GTE Synopsis GTE Report
CYP2D6 Genotyping for Tamoxifen
CYP450 Genotyping to Predict Response to Antipsychotic Drugs Pending
HERmark Breast Cancer Assay Pending
HLA-B*5701 Testing for Abacavir Hypersensitivity
Ki-67 (MKI67) Proliferation Marker Testing in Breast Cancer Pending
Oncotype DX (Breast Cancer)
DecisionDx-GBM Pending
PGxPredict Rituximab
PREZEON PTEN Gene Expression Test N/A *
PTEN Gene Expression Testing
ResponseDX: Colon N/A *
TOP2A Testing to Predict Treatment Response in Breast Cancer


* Indicates insufficient evidence for full report.

Stay Connected!

To receive webinar announcements, email newsletters, updates, and special offers from Hayes, click here to join our mailing lists.

Social Media